Digital Toolkit for Skin Diseases in LMICs

NCT05300399 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1364

Last updated 2022-09-27

No results posted yet for this study

Summary

To evaluate the early detection and effective management of skin diseases using the mHealth app in Cote d'Ivoire, a mixed-methods pilot trial will be conducted in Cote d'Ivoire. The pilot trial will consist of 3 phases: phase 1, development and improvement of the mHealth app; phase 2, pilot trial to evaluate the usability of the mHealth app for local healthcare providers in Cote d'Ivoire; and phase 3, pilot trial to evaluate the effectiveness of case detection and management of skin diseases with the mHealth app in Cote d'Ivoire. The pilot study will be implemented as a 2-arm trial with local healthcare providers and patients with skin diseases over a 3-month follow-up period.

Conditions

  • Skin Diseases

Interventions

DEVICE

mHealth app

The local healthcare providers will be assigned to an intervention group receiving the mHealth app to be used in their daily practices or a control group.

Sponsors & Collaborators

  • Osaka University

    collaborator OTHER
  • Hope Commission International

    collaborator UNKNOWN
  • Institut Pasteur of Cote d'Ivoire

    collaborator OTHER_GOV
  • Institut Raoul Follereau

    collaborator UNKNOWN
  • Centre Suisse de Recherches Scientifiques en Cote d'Ivoire

    collaborator OTHER
  • Trilobite, Ltd.

    collaborator UNKNOWN
  • Tulane University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-14
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • Côte d’Ivoire

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05300399 on ClinicalTrials.gov